Checkpoint inhibitors seem safe against cancer in HIV patients

Previously, they were excluded from clinical trials
HIV virus

In HIV-infected patients with a variety of advanced cancers, immune-checkpoint inhibitors appear to be effective and add no new risks, according to a new systematic review.